Human Granzyme H Antibody, R&D Systems™

Granzyme H

Polyclonal

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

Cathepsin G-like 2, CCP-X, CCP-Xcytotoxic T-lymphocyte-associated serine esterase 1, CGL2, CGL-2, CSP-Ccytotoxin serine protease-C, CTLA1, CTSGL2, CTSGL2granzyme H, Cytotoxic serine protease C, Cytotoxic T-lymphocyte proteinase, EC 3.4.21, EC 3.4.21.-, EC 3.4.21.79, granzyme H (cathepsin G-like 2, protein h-CCPX), GrzH, GZMH

Goat

Affinity Purified

RUO

2999

Reconstitute at 0.2 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

Western Blot, Immunoprecipitation, Immunocytochemistry

LYOPH

Western Blot 0.1 ug/mL, Immunoprecipitation 25 ug/mL, Immunocytochemistry 5-15 ug/mL

P20718

GZMH

Mouse myeloma cell line NS0-derived recombinant human Granzyme H Glu19-Leu246 Accession # P20718

25 μg

Primary

Detects both the pro and active forms of human Granzyme H in direct ELISAs and Western blots. In direct ELISAs, approximately 25% cross-reactivity with recombinant human Granzyme B is observed and approximately 5% cross-reactivity with recombinant mouse (rm) Granzyme C, rmGranzyme D, and rmGranzyme G is observed.

Human

IgG